KalVista Pharmaceuticals, Inc. (KALV) Operating Income (Loss) USD 2014 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • KalVista Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending January 31, 2024 was -$33.2 M, a 23% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending January 31, 2024 was -$124 M, a 16.8% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$111 M, a 14.8% decline from 2021.
  • KalVista Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$96.6 M, a 66.8% decline from 2020.
  • KalVista Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$57.9 M, a 42.9% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$124 M -$33.2 M -$6.21 M -23% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-11
Q3 2023 -$118 M -$29.7 M -$3.86 M -14.9% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-07
Q2 2023 -$114 M -$29.1 M -$2.78 M -10.6% May 1, 2023 Jul 31, 2023 10-Q 2023-09-07
Q1 2023 -$111 M -$31.7 M -$4.92 M -18.3% Feb 1, 2023 Apr 30, 2023 10-K 2023-07-10
Q4 2022 -$106 M -$26.9 M -$262 K -0.98% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-11
Q3 2022 -$106 M -$25.9 M -$2.28 M -9.66% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-07
Q2 2022 -$103 M -$26.3 M -$6.8 M -34.8% May 1, 2022 Jul 31, 2022 10-Q 2023-09-07
Q1 2022 -$96.6 M -$26.8 M -$8.77 M -48.6% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-10
Q4 2021 -$87.8 M -$26.7 M -$14 M -111% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-09
Q3 2021 -$73.8 M -$23.6 M -$10.8 M -84.7% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-08
Q2 2021 -$63 M -$19.5 M -$5.07 M -35.1% May 1, 2021 Jul 31, 2021 10-Q 2022-09-08
Q1 2021 -$57.9 M -$18 M -$9.09 M -101% Feb 1, 2021 Apr 30, 2021 10-K 2023-07-10
Q4 2020 -$48.8 M -$12.7 M +$67 K +0.53% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-10
Q3 2020 -$48.9 M -$12.8 M -$3.49 M -37.6% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-09
Q2 2020 -$45.4 M -$14.4 M -$4.88 M -51% May 1, 2020 Jul 31, 2020 10-Q 2021-09-09
Q1 2020 -$40.5 M -$8.96 M +$2.3 M +20.4% Feb 1, 2020 Apr 30, 2020 10-K 2022-07-07
Q4 2019 -$42.8 M -$12.7 M -$6.06 M -91.1% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-11
Q3 2019 -$36.8 M -$9.29 M -$4.4 M -89.8% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-10
Q2 2019 -$32.4 M -$9.56 M -$2.56 M -36.5% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 -$29.8 M -$11.3 M -$8.29 M -279% Feb 1, 2019 Apr 30, 2019 10-K 2021-07-13
Q4 2018 -$21.5 M -$6.66 M -$2.31 M -53.2% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-10
Q3 2018 -$19.2 M -$4.89 M +$1.04 M +17.6% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-03
Q2 2018 -$20.3 M -$7.01 M -$1.56 M -28.5% May 1, 2018 Jul 31, 2018 10-Q 2019-09-09
Q1 2018 -$18.7 M -$2.97 M +$1.88 M +38.8% Feb 1, 2018 Apr 30, 2018 10-K 2020-07-01
Q4 2017 -$20.6 M -$4.35 M +$3.77 M +46.5% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-14
Q3 2017 -$24.4 M -$5.94 M -$3.53 M -147% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-14
Q2 2017 -$20.8 M -$5.45 M +$1.51 M +21.7% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 -$22.3 M -$4.85 M +$1.68 M +25.7% Feb 1, 2017 Apr 30, 2017 10-K 2019-07-16
Q4 2016 -$24 M -$8.12 M -$4.3 M -113% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-16
Q3 2016 -$19.7 M -$2.41 M +$2.49 M +50.9% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-08
Q2 2016 -$22.2 M -$6.96 M -$1.3 M -22.9% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-12
Q1 2016 -$20.9 M -$6.53 M -$1.63 M -33.2% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q4 2015 -$19.3 M -$3.82 M +$2 K +0.05% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-16
Q3 2015 -$19.3 M -$4.9 M -$1.33 M -37.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$18 M -$5.67 M -$3.23 M -133% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$14.7 M -$4.9 M -$3.05 M -164% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$11.7 M -$3.82 M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$3.57 M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$2.44 M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$1.86 M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.